Showing 1491 - 1500 of 2227 for "Walalangi & Partners in association with Nishimura & Asahi" with applied filters
17 May 2023 by
The patent eligibility in every jurisdiction differs in content and form. It perhaps finds its justification in the stage of development the country is placed in relation to inventions of new technology or its adoption by the state technology groups.
16 May 2023 by
Recently, AnJie Broad Law Firm received a Consent Award signed by the international arbitrators, Mr. Philip Yang, Mr. Patrick O'Donovan, and Mr. Danny Mok, from the UK and Hong Kong
09 May 2023 by
On April 28, 2023, the India Habitat Centre in New Delhi was abuzz with over 100+ women professionals from different segments, all in attendance for the Women in IP Global Networking Event 2023 hosted by LexOrbis on behalf of the American Intellectual Property Law Association (AIPLA).
04 May 2023 by
In a recent Judgement, the Delhi High Court (“Court”) decided on an appeal filed by Microsoft Corporation to set aside the decision of Controller General of Patents and Designs (“Controller”) dated 05th March 2012 refusing the grant of Indian patent application 487/DELNP/2006 (“subject patent”) under Section 15 of the Patents Act.
25 April 2023 by
A recent decision by the German Federal Court of Justice has spurred interest in the international arbitration community regarding the interplay between a country’s antitrust laws and enforcement of foreign arbitral awards.
21 April 2023 by
Hong Kong has taken another step in developing the city as a leading international risk management center. On 28 March 2023, a US$350 million World Bank catastrophe bond was listed on the Hong Kong Stock Exchange .
20 April 2023 by
The Indian pharmaceutical market is one of the largest markets in the globe, both in terms of production and consumption. Several changes have been made to the patent and competition law due to the increasing challenges in the pharmaceutical market that directly impact the profit margin of pharmaceutical manufacturers. To increase these margins, pharmaceutical product manufacturing firms employ a variety of strategies. This article investigates the concept of “product hopping” and compares it with the practice of patent evergreening.
19 April 2023 by
asialaw's Lawyer of the Month for April 2023 is...
19 April 2023 by
asialaw's Deal of the Month for April 2023 is...
13 April 2023 by
Indonesia’s competition authority, the KPPU (Komisi Pengawas Persaingan Usaha), has issued a new merger filing regulation, KPPU Regulation No. 3 of 2023 regarding Evaluation of Merger, Consolidation, or Acquisition of Shares and/or Assets which May Result in Monopolistic Practices and/or Unfair Competition (“KPPU Reg 3/2023”). Because this regulation is so new, certain provisions may require further clarification. Nonetheless, based on the text of the regulation, the following appear to be the biggest changes under KPPU Reg 3/2023